The author is in the Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York
14853, USA. vmv1@cornell.edu
Two recent papers identify the first peptide inhibitor that binds to the structural protein of HIV-1, thereby blocking assembly of both immature and mature virus-like particles in vitro. These studies open the door to a strategy for the development of new therapies against the virus.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
